E
6657
vs
ABBV
E
6657
ABBV
Over the past 12 months, Energenesis Biomedical Co Ltd has underperformed ABBV, delivering a return of -36% compared to the ABBV's +2% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
6657
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
E
Intrinsic Value
5.12
TWD
Overvaluation 89%
ABBV
Intrinsic Value
228.22
USD
Undervaluation 4%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
48.55
TWD
|
|||||
|
Abbvie Inc
NYSE:ABBV
|
219.68
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
6657, ABBV
6657, ABBV
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
E
|
Energenesis Biomedical Co Ltd
Revenue
|
|||||||||||
|
|
Abbvie Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6657, ABBV
6657, ABBV
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
|||||||||
|
|
Abbvie Inc
NYSE:ABBV
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Energenesis Biomedical Co Ltd
77.3%
ABBV
71.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
Operating Margin
Energenesis Biomedical Co Ltd
-3 499.2%
ABBV
34.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
Net Margin
Energenesis Biomedical Co Ltd
-3 267.7%
ABBV
6.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
FCF Margin
Energenesis Biomedical Co Ltd
-2 778.9%
ABBV
29.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
ROE
Energenesis Biomedical Co Ltd
-29.8%
ABBV
15 221.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
ROA
Energenesis Biomedical Co Ltd
-28.6%
ABBV
3.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
ROIC
Energenesis Biomedical Co Ltd
-158.3%
ABBV
14%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
ROCE
Energenesis Biomedical Co Ltd
-31.6%
ABBV
22.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Energenesis Biomedical Co Ltd | ||||
|
|
Abbvie Inc | ||||
Solvency Comparison
E
Energenesis Biomedical Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
6657, ABBV
6657, ABBV
Performance By Year
6657, ABBV
6657, ABBV
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 6657 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Energenesis Biomedical Co Ltd
AMGN
Amgen Inc
Cheaper
vs Energenesis Biomedical Co Ltd
GILD
Gilead Sciences Inc
Cheaper
vs Energenesis Biomedical Co Ltd
VRTX
Vertex Pharmaceuticals Inc
Cheaper
vs Energenesis Biomedical Co Ltd
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
